Dossier
deadly skin cancer
Coverage of deadly skin cancer in the Nexus archive.
- Cancer vaccine slashes risk of deadly skin cancer returning by nearly half in major trial
A cancer vaccine reduced the risk of deadly skin cancer returning by nearly half in a major clinical trial. The trial demonstrated the vaccine's effectiveness in preventing recurrence of the disease.